10320-49-7Relevant articles and documents
-
Pelletier
, p. 313 (1952)
-
SMALL MOLECULE CMKLR1 ANTAGONISTS IN INFLAMMATORY DISEASE
-
Paragraph 0199; 0230; 0232, (2020/12/01)
α-NETA analogs are provided for the treatment of inflammatory disease.
New 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols with antituberculosis activity
Omel’kov,Fedorov,Stepanov
, p. 1908 - 1918 (2019/10/22)
New 4-dimethylamino-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols with antituberculosis activity were synthesized. (1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate exhibiting high
PYRIDINE DERIVATIVES AND APPLICATION OF ANTI-MACOBACTERIUM THEREOF
-
Paragraph 0342; 0343, (2016/10/08)
The present invention provides a series of pyridine derivatives and their preparation method and application thereof. The series of pyridine derivatives can be applied to treating mycobacterium-related diseases, especially to treatments of fatal mycobacterium-related diseases. The fatal diseases may be related to mycobacterium tuberculosis, mycobacterium bovis, mycobacterium avium, and mycobacterium marinum.